Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cerner (CERN) PT Raised to $80 at Cantor Fitzgerald
-
WellCare Health Plans (WCG) PT Raised to $275 at Cantor Fitzgerald
-
U.S. yields fall as Wall Street turns lower
-
Efficient Market Advisors Named to Financial Times' 2018 List of Top 300 RIAs
-
Allegro Merger Corp. (ALGRU) Prices 13M Unit IPO at $10/Unit
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Pre-Open Movers 07/02: (ADMP) (VMW) (TSLA) Higher; (MDXG) (MLCO) (LVS) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Melinta Therapeutics Inc. (MLNT) at Overweight
-
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
-
Cantor Fitzgerald Starts Marinus Pharmaceuticals (MRNS) at Overweight
-
U.S. SEC accuses ex-Cantor Fitzgerald brokers of secret commission sharing
-
Dermira (DERM): FDA Approval of Qbrexza is Positive and Co. is Well Funded Through Launch - Cantor Fitzgerald
-
Accenture plc (ACN) PT Raised to $185 at Cantor Fitzgerald
-
World stocks up slightly Friday, but down for June as U.S. trade policy unnerves investors
-
Thunder Bridge Acquisition, Ltd. Announces Closing of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering
-
Max Sound Asks SEC & FINRA to Accelerate Investigations On Naked Shorting & Failure to Deliver Shares
-
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
-
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
-
Cantor Fitzgerald Not Worried About Amazon's (AMZN) Entry Into Prescription Market
-
Cantor Fitzgerald Remains Bullish on Arsanis, Inc (ASNS) Following ASN100 Phase 2 Discontinuation
-
Cantor Fitzgerald Reiterates Overweight on Amarin Corp. (AMRN) Following Last Patient Study Visit in REDUCE-IT
-
Amazon to buy PillPack in potentially disruptive drug retail push
-
Cantor Fitzgerald Reiterates Overweight on Neos Therapeutics (NEOS) Following Management Changes
-
CohBar Completes Sale of $20 Million Under Controlled Equity Offering
-
CohBar Completes Sale of $20 Million Under Controlled Equity Offering
-
Cantor Fitzgerald Downgrades Aquinox Pharmaceutical (AQXP) to Neutral
-
UPDATE: Global Blood Therapeutics (GBT) PT Raised to Street High $96 at Cantor Fitzgerald
-
Makor Enters Strategic Partnership With Investre
-
Layton Road Group Welcomes Managing Director Daniel Cohen
-
Cantor Fitzgerald Reiterates Overweight on Apellis Pharmaceuticals (APLS) Following R&D Day
-
PolarityTE (COOL) Bullish View Reiterated at Cantor Fitzgerald Following Call
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
SELLAS Life Sciences (SLS) Plans 6.08M Share Public Offering of Common Stock
-
SELLAS Life Sciences Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald to Host Conf Call with PolarityTE (COOL) Management Tomorrow
-
Long-dated notes gain on trade war, Europe concerns
-
GW Pharma (GWPH) PT Raised to Street High $235 at Cantor Fitzgerald
-
Kindred Biosciences (KIN) Reports Exercise of Option by Underwriters to Purchase Additional 694.74K Shares at $9.50/Sh
-
Kindred Biosciences Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
-
Array BioPharma (ARRY) PT Raised to $26 at Cantor Fitzgerald
-
electroCore (ECOR) IPO Opens 20% Higher
-
electroCore, Inc. (ECOR) Prices 5.2M Share IPO at $15/Sh
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
Thunder Bridge Acquisition, Ltd. Announces Closing of $225,000,000 Initial Public Offering
-
Two More Positive HTX-011 Studies Supports Bullish Heron Therapeutics (HRTX) Thesis - Cantor Fitzgerald
-
UPDATE: Quality Systems (QSII) PT Raised to $23 at Cantor Fitzgerald
-
Kindred Biosciences (KIN) Prices 4.63M Share Common Offering at $9.50/Sh

